EUVIMEDEUVIMED entdecken
Crossref

A Novel Three Small Molecule Inhibitor Combination Therapy For Prostate Cancer

Ummuhan Demir, Hilal Badoglu, Irem Nur Cetin, Muhammed Yasar Bener

Anticancer Research · 2025

DOI: 10.21873/anticanres.17672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Ummuhan Demir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Istanbul Medeniyet University, Istanbul, Turkiye ummuhan.d…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Pyrvinium Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Prostate cancer is common in elderly men. Single treatment options are inadequate for effective therapy. In this study, three small-molecule inhibitors targeting three different pathways related to stemness were combined to obtain an effective antiproliferative effect on prostate cancer cell lines. These small molecules and their corresponding target were: KJ-Pyr-9 as an inhibitor of MYC proto-oncogene bHLH transcription factor (MYC); pyrvinium pamoate as an inhibitor of WNT; and glasdegib as an inhibitor of Sonic Hedgehog (SHH), which induces stem cell properties of cells. MATERIALS AND METHODS: Firstly, the half-maximal inhibitory concentration (IC50) and IC25 doses of each drug against the PC-3 cell line and dose optimization for combination of all three drugs were determined. PNT1A cells were used as a healthy control. 3D culture and scratch assays were applied to test efficiency of combined drug treatment. RESULTS: According to 2D culture results, the combination was synergistic in PC-3 while its effect was minimal in PNT1A. The combined treatment diminished both viability and size of 3D spheroids of PC-3 and LNCaP cells. In addition, the combined treatment reduced the migratory potential of PC-3 and LNCaP cells. CONCLUSION: The combined treatment proposed in this study is novel and promising in overcoming drug resistance and side-effects of single agents and may herald a new era in the treatment paradigm for prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsPyrvinium CompoundsHumansMaleProto-Oncogene MasCell Line, TumorCell ProliferationCell MovementDrug SynergismProto-Oncogene Proteins c-mycHedgehog ProteinsCell SurvivalPC-3 Cells

Stichwörter der Autor:innen

Combination therapyKJ-Pyr-9cancer stem cell propertiesglasdegibpyrvinium pamoatesynergism

Substanzen

Proto-Oncogene MasMAS1 protein, humanPyrvinium CompoundsProto-Oncogene Proteins c-mycHedgehog Proteins

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Istanbul Medeniyet University, Istanbul, Turkiye ummuhan.demir@medeniyet.edu.tr.
  • Science and Advanced Technologies Research Center (BILTAM), Istanbul Medeniyet University, Istanbul, Turkiye.
  • Department of Molecular Biology and Genetics, Institute of Graduate Programs, Istanbul Technical University, Istanbul, Turkiye.
  • Department of Molecular Biology and Genetics, Institute of Graduate Programs, Gebze Technical University, Istanbul, Turkiye.
  • Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Istanbul Medeniyet University, Istanbul, Turkiye.

Zitieren

APA

Demir, U., Badoglu, H., Cetin, I. N., & Bener, M. Y. (2025). A Novel Three Small Molecule Inhibitor Combination Therapy For Prostate Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17672

Vancouver

Demir U, Badoglu H, Cetin IN, Bener MY. A Novel Three Small Molecule Inhibitor Combination Therapy For Prostate Cancer. Anticancer Research. 2025. doi:10.21873/anticanres.17672

BibTeX
@article{Demir2025,
  author = {Demir, Ummuhan and Badoglu, Hilal and Cetin, Irem Nur and Bener, Muhammed Yasar},
  title = {A Novel Three Small Molecule Inhibitor Combination Therapy For Prostate Cancer},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17672}
}
Kostenlos starten →